Publications
Racial differences in serum chemokines in prostate cancer patients
Karan, D,
Wick, J,
Dubey, S,
Kumar-Sinha, C,
Siddiqui, J,
Kunju, LP,
Iczkowski, KA,
Chinnaiyan, AM,
Cancer, 2023 Sep; DOI:10.1002/cncr.35012 Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin
Liang, W-W,
Lu, RJ-H,
Jayasinghe, RG,
Foltz, SM,
Porta-Pardo, E,
Geffen, Y,
Wendl, MC,
Lazcano, R,
Kolodziejczak, I,
Song, Y,
Govindan, A,
Demicco, EG,
Li, X,
Li, Y,
Sethuraman, S,
Payne, SH,
Fenyö, D,
Rodriguez, H,
Wiznerowicz, M,
Shen, H,
Mani, DR,
Rodland, KD,
Lazar, AJ,
Robles, AI,
Ding, L,
Clinical Proteomic Tumor Analysis Consortium, Array,
Cancer Cell, 2023 Sep; DOI:10.1016/j.ccell.2023.07.013 Proteogenomic insights suggest druggable pathways in endometrial carcinoma
Dou, Y,
Katsnelson, L,
Gritsenko, MA,
Hu, Y,
Reva, B,
Hong, R,
Wang, Y-T,
Kolodziejczak, I,
Lu, RJ-H,
Tsai, C-F,
Bu, W,
Liu, W,
Guo, X,
An, E,
Arend, RC,
Bavarva, J,
Chen, L,
Chu, RK,
Czekański, A,
Davoli, T,
Demicco, EG,
DeLair, D,
Devereaux, K,
Dhanasekaran, SM,
Dottino, P,
Dover, B,
Fillmore, TL,
Foxall, M,
Hermann, CE,
Hiltke, T,
Hostetter, G,
Jędryka, M,
Jewell, SD,
Johnson, I,
Kahn, AG,
Ku, AT,
Kumar-Sinha, C,
Kurzawa, P,
Lazar, AJ,
Lazcano, R,
Lei, JT,
Li, Y,
Liao, Y,
Lih, T-SM,
Lin, T-T,
Martignetti, JA,
Masand, RP,
Matkowski, R,
McKerrow, W,
Mesri, M,
Monroe, ME,
Moon, J,
Moore, RJ,
Nestor, MD,
Newton, C,
Omelchenko, T,
Omenn, GS,
Payne, SH,
Petyuk, VA,
Robles, AI,
Rodriguez, H,
Ruggles, KV,
Rykunov, D,
Savage, SR,
Schepmoes, AA,
Shi, T,
Shi, Z,
Tan, J,
Taylor, M,
Thiagarajan, M,
Wang, JM,
Weitz, KK,
Wen, B,
Williams, CM,
Wu, Y,
Wyczalkowski, MA,
Yi, X,
Zhang, X,
Zhao, R,
Mutch, D,
Chinnaiyan, AM,
Smith, RD,
Nesvizhskii, AI,
Wang, P,
Wiznerowicz, M,
Ding, L,
Mani, DR,
Zhang, H,
Anderson, ML,
Rodland, KD,
Zhang, B,
Liu, T,
Fenyö, D,
Clinical Proteomic Tumor Analysis Consortium, Array,
Cancer Cell, 2023 Sep; DOI:10.1016/j.ccell.2023.07.007 A Review of the Clinical Applications of Artificial Intelligence in Abdominal Imaging
Mervak, BM,
Fried, JG,
Wasnik, AP,
Diagnostics (Basel), 2023 Sep; DOI:10.3390/diagnostics13182889 Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer
Hwang, C,
Henderson, NC,
Chu, S-C,
Holland, B,
Cackowski, FC,
Pilling, A,
Jang, A,
Rothstein, S,
Labriola, M,
Park, JJ,
Ghose, A,
Bilen, MA,
Mustafa, S,
Kilari, D,
Pierro, MJ,
Thapa, B,
Tripathi, A,
Garje, R,
Ravindra, A,
Koshkin, VS,
Hernandez, E,
Schweizer, MT,
Armstrong, AJ,
McKay, RR,
Dorff, TB,
Alva, AS,
Barata, PC,
JAMA Netw Open, 2023 Sep; DOI:10.1001/jamanetworkopen.2023.34208 Genome-wide open reading frame profiling identifies fibroblast growth factor signaling as a driver of PD-L1 expression in head and neck squamous cell carcinoma
Mann, JE,
Smith, JD,
Kulkarni, A,
Foltin, SK,
Scheftz, EB,
Murray, IR,
Gensterblum-Miller, E,
Brummel, CV,
Bhangale, A,
Hoesli, RC,
Brenner, JC,
Oral Oncol, 2023 Sep; DOI:10.1016/j.oraloncology.2023.106562 Hidden Disparities: How Language Influences Patients’ Access to Cancer Care
Chen, DW,
Banerjee, M,
He, X,
Miranda, L,
Watanabe, M,
Veenstra, CM,
Haymart, MR,
J Natl Compr Canc Netw, 2023 Sep; DOI:10.6004/jnccn.2023.7037 Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695)
Flaig, TW,
Tangen, CM,
Daneshmand, S,
Alva, AS,
Lucia, MS,
McConkey, DJ,
Theodorescu, D,
Goldkorn, A,
Milowsky, MI,
Bangs, R,
MacVicar, GR,
Bastos, BR,
Fowles, JS,
Gustafson, DL,
Plets, M,
Thompson, IM,
Lerner, SP,
Eur Urol, 2023 Sep; DOI:10.1016/j.eururo.2023.06.014 Sometimes It Really Is the Zebra: A Rare Case of Infantile Giant Cell Fibroblastoma
Alessio-Bilowus, D,
Sacks, GN,
Luby, AO,
Heider, A,
Vercler, CJ,
Face, 2023 Sep; DOI:10.1177/27325016231179237 A primer on rectal MRI in patients on watch-and-wait treatment for rectal cancer
Gollub, MJ,
Costello, JR,
Ernst, RD,
Lee, S,
Maheshwari, E,
Petkovska, I,
Wasnik, AP,
Horvat, N,
Abdom Radiol (NY), 2023 Sep; DOI:10.1007/s00261-023-03900-6 Sequence of colorectal and liver resection in patients with surgically-treatable stage IV colorectal cancer
Harbaugh, C,
Damle, A,
Seminars in Colon and Rectal Surgery, 2023 Sep; DOI:10.1016/j.scrs.2023.100969 MyProstateScore in men considering repeat biopsy: validation of a simple testing approach
Tosoian, JJ,
Sessine, MS,
Trock, BJ,
Ross, AE,
Xie, C,
Zheng, Y,
Samora, NL,
Siddiqui, J,
Niknafs, Y,
Chopra, Z,
Tomlins, S,
Kunju, LP,
Palapattu, GS,
Morgan, TM,
Wei, JT,
Salami, SS,
Chinnaiyan, AM,
Prostate Cancer Prostatic Dis, 2023 Sep; DOI:10.1038/s41391-022-00633-3 INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) consensus statement: Imaging recommendations for the management of rhabdomyosarcoma
Schoot, RA,
van Ewijk, R,
von Witzleben, A-A,
Kao, SC,
Merks, JHMH,
Morosi, C,
Pace, E,
Shulkin, BL,
Ferrari, A,
von Kalle, T,
van Rijn, RR,
Weiss, AR,
Sparber-Sauer, M,
Ter Horst, SAJ,
McCarville, MB,
Eur J Radiol, 2023 Sep; DOI:10.1016/j.ejrad.2023.111012 Short Report of a Phase II Trial of Nintedanib in Recurrent Malignant Pleural Mesothelioma (MPM)
Wozniak, AJ,
Schneider, B,
Kalemkerian, GP,
Daly, B,
Chen, W,
Ventimiglia, J,
Nagasaka, M,
Zauderer, MG,
Clin Lung Cancer, 2023 Sep; DOI:10.1016/j.cllc.2023.04.004 Survival Prediction of Patients with Bladder Cancer after Cystectomy Based on Clinical, Radiomics, and Deep-Learning Descriptors
Sun, D,
Hadjiiski, L,
Gormley, J,
Chan, H-P,
Caoili, EM,
Cohan, RH,
Alva, A,
Gulani, V,
Zhou, C,
Cancers (Basel), 2023 Sep; DOI:10.3390/cancers15174372 Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma.
Dehner, CA,
Bell, RC,
Cao, Y,
He, K,
Chrisinger, JSA,
Armstrong, AE,
Yohe, M,
Shern, J,
Hirbe, AC,
JCO Precis Oncol, 2023 Sep; DOI:10.1200/PO.23.00037 Performance of axial diameter on MR imaging for identification of retropharyngeal lymph node metastases in head and neck cancer: a systematic review and meta-analysis
Baba, A,
Kurokawa, R,
Kurokawa, M,
Rivera-de Choudens, R,
Srinivasan, A,
Neuroradiology, 2023 Sep; DOI:10.1007/s00234-023-03205-x New technology in prostate cancer and financial toxicity
Maganty, A,
Hollenbeck, BK,
Urol Oncol, 2023 Sep; DOI:10.1016/j.urolonc.2023.04.014 Pan-cancer proteogenomics connects oncogenic drivers to functional states
Li, Y,
Porta-Pardo, E,
Tokheim, C,
Bailey, MH,
Yaron, TM,
Stathias, V,
Geffen, Y,
Imbach, KJ,
Cao, S,
Anand, S,
Akiyama, Y,
Liu, W,
Wyczalkowski, MA,
Song, Y,
Storrs, EP,
Wendl, MC,
Zhang, W,
Sibai, M,
Ruiz-Serra, V,
Liang, W-W,
Terekhanova, NV,
Rodrigues, FM,
Clauser, KR,
Heiman, DI,
Zhang, Q,
Aguet, F,
Calinawan, AP,
Dhanasekaran, SM,
Birger, C,
Satpathy, S,
Zhou, DC,
Wang, L-B,
Baral, J,
Johnson, JL,
Huntsman, EM,
Pugliese, P,
Colaprico, A,
Iavarone, A,
Chheda, MG,
Ricketts, CJ,
Fenyö, D,
Payne, SH,
Rodriguez, H,
Robles, AI,
Gillette, MA,
Kumar-Sinha, C,
Lazar, AJ,
Cantley, LC,
Getz, G,
Ding, L,
Clinical Proteomic Tumor Analysis Consortium, Array,
Cell, 2023 Aug; DOI:10.1016/j.cell.2023.07.014 Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Geffen, Y,
Anand, S,
Akiyama, Y,
Yaron, TM,
Song, Y,
Johnson, JL,
Govindan, A,
Babur, Ö,
Li, Y,
Huntsman, E,
Wang, L-B,
Birger, C,
Heiman, DI,
Zhang, Q,
Miller, M,
Maruvka, YE,
Haradhvala, NJ,
Calinawan, A,
Belkin, S,
Kerelsky, A,
Clauser, KR,
Krug, K,
Satpathy, S,
Payne, SH,
Mani, DR,
Gillette, MA,
Dhanasekaran, SM,
Thiagarajan, M,
Mesri, M,
Rodriguez, H,
Robles, AI,
Carr, SA,
Lazar, AJ,
Aguet, F,
Cantley, LC,
Ding, L,
Getz, G,
Clinical Proteomic Tumor Analysis Consortium, Array,
Cell, 2023 Aug; DOI:10.1016/j.cell.2023.07.013 451. ISOFORM SWITCHING EVENTS MAY PROVIDE NEW INSIGHT FOR THE IDENTIFICATION OF PROGNOSTIC AND THERAPEUTIC TARGETS IN ESOPHAGEAL ADENOCARCINOMA
Zhang, Y,
Howard, C,
Israel, R,
Vandenburg, B,
Barnett, S,
Riethoven, J-J,
Clarke, J,
Lagisetty, K,
Lin, J,
Reddy, R,
Chang, A,
Kresty, LA,
Diseases of the Esophagus, 2023 Aug; DOI:10.1093/dote/doad052.239 375. RURAL PATIENTS HAVE A PROLONGED INPATIENT RECOVERY PROCESS AFTER ESOPHAGECTOMY COMPARED TO NON-RURAL PATIENTS AT A HIGH-VOLUME ESOPHAGEAL PROGRAM
Schroeder, J,
Lagisetty, K,
Lynch, W,
Lin, J,
Chang, A,
Orringer, M,
Reddy, R,
Diseases of the Esophagus, 2023 Aug; DOI:10.1093/dote/doad052.180 Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance
Rasool, RU,
O'Connor, CM,
Das, CK,
Alhusayan, M,
Verma, BK,
Islam, S,
Frohner, IE,
Deng, Q,
Mitchell-Velasquez, E,
Sangodkar, J,
Ahmed, A,
Linauer, S,
Mudrak, I,
Rainey, J,
Zawacki, KP,
Suhan, TK,
Callahan, CG,
Rebernick, R,
Natesan, R,
Siddiqui, J,
Sauter, G,
Thomas, D,
Wang, S,
Taylor, DJ,
Simon, R,
Cieslik, M,
Chinnaiyan, AM,
Busino, L,
Ogris, E,
Narla, G,
Asangani, IA,
Nat Commun, 2023 Aug; DOI:10.1038/s41467-023-40760-6 Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors
Mumphrey, MB,
Hosseini, N,
Parolia, A,
Geng, J,
Zou, W,
Raghavan, M,
Chinnaiyan, A,
Cieslik, M,
Cell Rep, 2023 Aug; DOI:10.1016/j.celrep.2023.112965 The nutritional supplement taurine activates p53-dependent and independent tumor suppressor mechanisms in various cellular models of ovarian cancer.
Centeno, D,
Farsinejad, S,
Kochetkova, E,
Volpari, T,
Klupczynska-Gabryszak, A,
Kung, D,
Polotaye, T,
Hyde, E,
Greenberg, M,
Pavlovic, T,
Alshehri, S,
Sullivan, W,
Plewa, S,
Vakifahmetoglu-Norberg, H,
Monsma, FJ,
Muller, PAJ,
Matysiak, J,
Zaborowski, M,
DiFeo, A,
Andres-Martin, L,
Norberg, E,
Iwanicki, M,
2023 Aug; DOI:10.1101/2023.02.24.529893 